“…Therefore, the promising results of SCSinduced CBF augmentation have led some clinicians to use this procedure to treat various cerebral vascular disorders. These cerebral diseases and/or pathological conditions include cerebral ischemia (Broseta et al, 1994;De Andres et al, 2007;Hosobuchi, 1991), ischemic spastic hemiparesis (Visocchi et al, 1994), focal cerebral ischemia (Meglio et al, 1991a, b;Ebel et al, 2001;Sagher et al, 2003;Sagher and Huang 2006;Robaina et al, 2004), cerebral vasospasm Karadag et al, 2005;Visocchi et al, 2001), stroke (Hosobuchi, 1991;Matsui and Hosobuchi, 1989;Visocchi et al, 1994Visocchi et al, , 2001, ischemic cerebral oedema (Gonzalez-Darder and Canadas-Rodriguez, 1991), postapoplectic spastic hemiplegia (Nakamura and Tsubokawa, 1985), prolonged coma (Fujii et al, 1998), persistent vegetative state (Funahashi et al 1989;Kanno et al, 1987;Kuwata, 1993), as well as migraine and posttraumatic cervicogenic headache (Dario et al, 2005). However, the underlying mechanisms of blood flow improvement are not well understood ).…”